Center of Psychotherapy, Psychosomatics and Psychedelic Medicine Expio

Opening Hours : Mon-Fri 10.00 - 19.00.

Tel. +380 7373 080 88

Archive for January 2024

econ

New therapy for wounded Ukrainian soldiers: ketamine

Psychedelics can help them overcome their trauma and possibly fight back

Ihor Kholodylo was probably not supposed to survive. A military psychologist and medic was evacuating his comrades in early 2023 when his jeep was hit by a Russian tank shell. He remained barely able to communicate. The operation saved his heart and eyesight. But doctors were unable to correct his speech problem and stuttering. He tried all kinds of radical therapy, but nothing helped. Then he met Vladyslav Matrenytskyi, a pioneer of psychedelic psychotherapy, who asked an unexpected question. Would he try ketamine?

Mr. Cold did not expect much, but the result was amazing. After one session, his stuttering was almost gone. Five more and he was almost back to normal. Gone are the nightmares and fears about everyday life. Ketamine therapy wasn't easy, he said, but it allowed him to resolve the trauma that was causing his symptoms: "I was back to what you could call life ... I felt light, just blessed."

Read More
psychedelics_PTSD

The US Congress approved a bill on military research into psychedelic drugs

Last week, Congress approved a defense spending bill that will fund military research and clinical trials of cannabis, psilocybin and other psychedelic drugs to determine their effectiveness in treating service members and veterans with post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Adoption of section 723 Law on Authorization for National Defense (NDAA) would allow members of the military to undergo psychedelic therapy and provide $10 million to explore this option as a new approach to mental health treatment.

Details about the new draft law

Back in June, the Senate Appropriations Committee proposed military spending bill , which contains several requests for the 2024 military construction budget. Among these requests was an important directive to expand research into the therapeutic benefits of psychedelics. The committee urged the Department of Veterans Affairs (VA) to investigate the potential of these substances to treat various health conditions common among veterans, such as post-traumatic stress disorder, major depressive disorder, and chronic pain. This directive was a crucial component of a broader approach to treating veterans' mental health through psychedelic therapy.

Read More